›› 2008, Vol. 3 ›› Issue (01): 61-64.

• 综述 • 上一篇    下一篇

阿司匹林抵抗的概念缺乏临床意义

施仲伟   

  1. 上海市上海交通大学医学院瑞金医院心脏科
  • 收稿日期:2007-11-21 修回日期:2007-10-21 出版日期:2008-01-20 发布日期:2008-01-20
  • 通讯作者: 施仲伟

Aspirin Resistance: An Idea without Clinically Practical Significance

Shizhongwei   

  • Received:2007-11-21 Revised:2007-10-21 Online:2008-01-20 Published:2008-01-20
  • Contact: Shizhongwei

摘要: 阿司匹林抵抗涉及临床抵抗和生化抵抗两种定义。临床阿司匹林抵抗是指患者尽管服用阿司匹林,仍然发生了心脑血管病事件。但是这一概念忽略了心脑血管病发生发展过程的复杂性,而将各种已知或未知致病因素的临床后果都归因于阿司匹林抵抗;生化阿司匹林抵抗是指患者服用阿司匹林后不能使一种或几种血小板功能试验达到预期的抑制效果。目前常用的血小板聚集或抑制试验缺乏统一的检测方法和评价标准,试验结果缺乏特异性、敏感性和可重复性,缺乏与体内实际血小板功能状态以及临床事件相关性的研究。因此,目前有关阿司匹林抵抗这一概念缺乏临床实用价值。

关键词: 阿司匹林抵抗; 心血管疾病; 血小板聚集; 血栓素A2

Abstract: Aspirin resistance has two definitions. Clinical aspirin resistance is defined aspatients taking aspirin unable free from ischemic cardiovascular events. This definition ignores thecomplexity of pathogenesis of cardiovascular diseases. Furthermore, it is not realistic to expectthat all vascular complications can be prevented by single preventive strategy. Biochemical aspirinresistance means aspirin cannot produce an anticipated effect on one or more laboratory testsof platelet function when taking aspirin, such as inhibiting platelet aggregation or biosynthesisof thromboxane. However, the methodologies of these tests have not yet been standardized. Theresults of these experiments are lacking in specificity, sensitivity and reproducibility. The clinicalrelevance has not been established. Therefore, at present, aspirin resistance is only an idea withoutclinical significance.

Key words: Aspirin resistance; Cardiovascular disease; Platelet aggregation; Thromboxane A2